| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 09/18/2008 | WO2008112004A2 ANTIBODIES DIRECTED TO αVβ6 AND USES THEREOF |
| 09/18/2008 | WO2008112003A2 Targeted binding agents directed to pdgfr-alpha and uses thereof |
| 09/18/2008 | WO2008111634A1 Biomarker specific to brain/nerve or specific to neuronal differentiation |
| 09/18/2008 | WO2008110937A2 Antibodies against h5n1 strains of influenza a virus |
| 09/18/2008 | WO2008110653A1 Antibody producing microorganism, elements required to obtain same, resulting antibodies, therapeutic compositions and use of thereof |
| 09/18/2008 | WO2008110379A2 Monoclonal antibodies for treatment of cancer |
| 09/18/2008 | WO2008110373A1 Method of providing human tumor-specific antibodies |
| 09/18/2008 | WO2008110372A1 Monoclonal human tumor-specific antibody |
| 09/18/2008 | WO2008110348A1 Sequence based engineering and optimization of single chain antibodies |
| 09/18/2008 | WO2008090177A3 Diagnosis of prostate cancer |
| 09/18/2008 | WO2008088849A3 Inflammation treatment, detection and monitoring via trem-1 |
| 09/18/2008 | WO2008076379A3 Human antibodies to human delta like ligand 4 |
| 09/18/2008 | WO2008045505A3 Compositions, methods and kits for isolating nucleic acids from body fluids using anion exchange media |
| 09/18/2008 | WO2008045437A3 Chimeric t-cell receptors and t-cells targeting egfrviii on tumors |
| 09/18/2008 | WO2008036970A3 Insulin-degrading enzyme mutants and methods of use |
| 09/18/2008 | WO2008030564A3 Aglycosylated antibodies and methods of making and using those antibodies |
| 09/18/2008 | WO2008011446A3 Human glp-1 mimetibodies, compositions, methods and uses |
| 09/18/2008 | WO2007149948A3 Compositions and methods for diagnosis and treatment of tumors |
| 09/18/2008 | WO2007143701A3 Monoclonal antibodies that potently neutralize hepatitis c virus (hcv) of diverse genotypes |
| 09/18/2008 | US20080229453 Expression vector comprising nucleotide sequences coding serine/threonine kinase for use in propagating transgenic planys with seeds comprising enhanced lipid and fatty acid storage |
| 09/18/2008 | US20080229438 Plasmid comprising nucleotide sequences coding human growth hormone for use in transformation and propagation in bovine embryos; bioreactors |
| 09/18/2008 | US20080227959 Immunogenic compounds for producing antibodies to efavirenz; monoclonal antibodies; immunoassays for selectively determining efavirenz levels in plasma; treatment failure and central nervous system side effects due to low and high plasma levels, respectively |
| 09/18/2008 | US20080227958 Fc receptor specific immunoglobulin for use in diagnosis, prevention and treament of autoimmune disorders |
| 09/18/2008 | US20080227957 Reducing Immunogenicities of Immunoglobulins by Framework-Patching |
| 09/18/2008 | US20080227956 Novel morphogenic protein compositions of matter |
| 09/18/2008 | US20080227737 Comprises nucleotide sequences for use as diagnostic tools in identifying allelic sequences associated with blood sugar defects |
| 09/18/2008 | US20080227719 administering to a patient an effective dosage of a polypeptide comprising an N-terminal segment of A beta , the segment beginning at residue 1-3 of A beta and ending at residues 7-11 of A beta to treat disease associated with amyloid deposit of A beta in the brain Alzheimer's disease, Down's syndrome |
| 09/18/2008 | US20080227718 administering to a patient an effective dosage of a polypeptide comprising an N-terminal segment of A beta , the segment beginning at residue 1-3 of A beta and ending at residues 7-11 of A beta to treat disease associated with amyloid deposit of A beta in the brain Alzheimer's disease, Down's syndrome |
| 09/18/2008 | US20080227713 amino acid sequence of Ser1-Pro2-Lys3-Met4-Val5-Gln6-Gly7-Ser8-Gly9-Cys10-Phe11-Gly12-Arg13-Lys14-Met15-Asp16-Arg17-Ile18-Ser19-Ser20-Ser21-Ser22-Gly23-Leu24-Gly25-Cys26-Lys27-Val28-Leu29-Arg30-Lys31-His32, either Met4, Met15, or both are oxidized; diagnosis heart failure |
| 09/18/2008 | US20080227712 Polypeptide for use in treatment and prevention of leukemia, hemophilia and nervous system disorders |
| 09/18/2008 | US20080227711 Cxc-Chemokine Antagonists |
| 09/18/2008 | US20080227707 Bioactive peptides and unique ires elements from myelin proteolipid protein plp/dm20 |
| 09/18/2008 | US20080227704 CXCL13 binding proteins |
| 09/18/2008 | US20080227703 neublastin neurotrophic factor polypeptides for treating neuropathy |
| 09/18/2008 | US20080227685 Polypeptide comprising the amino acid sequence Cys Cys Glu Tyr Cys Cys Asn Pro Ala Cys Thr Gly Cys (SEQ ID NO:125); activating guanylate cyclase C (GC-C) receptor; gastroesophageal reflux disease, Crohn's disease, ulcerative colitis, Inflammatory bowel disease, dyspepsia, constipation |
| 09/18/2008 | US20080227200 Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell and hematopoietic progenitor cell, and DNA coding for the same |
| 09/18/2008 | US20080227199 Method for simultaneous production of multiple proteins; vectors and cells for use therein |
| 09/18/2008 | US20080227198 Using anti-CD80 antibody to induce lymphocyte response which targets B cell malignancies |
| 09/18/2008 | US20080227196 Mammalian cells defective in 1,6-fucosyltransferase activity for generating antibodies which target tumor cells |
| 09/18/2008 | US20080227194 Lipolytic enzyme specific antibody for use in diagnosis of pancreatitis |
| 09/18/2008 | US20080227192 Nematode ATP Synthase Subunit E-Like Sequences |
| 09/18/2008 | US20080227169 Immobilization |
| 09/18/2008 | US20080227158 Novel polypeptide, novel dna and novel antibody |
| 09/18/2008 | US20080227151 Method for simultaneous production of multiple proteins; vectors and cells for use therein |
| 09/18/2008 | US20080227149 Interferon-Alpha Polypeptides and Conjugates |
| 09/18/2008 | US20080227132 Hydrolase Enzymes and Their Use in Kinetic Resolution |
| 09/18/2008 | US20080227127 Human NK3-Related Prostate Specific Gene-1 |
| 09/18/2008 | US20080227125 Using cardiovascular disorder plasma polypeptides (CPPs) as evaluative tools in detection coronary artery disease |
| 09/18/2008 | US20080227123 Methods for Specifically Selecting Antibody-Producing Cells |
| 09/18/2008 | US20080227122 P2y purinergic receptor expression for identifying preneoplastic and neoplastic states |
| 09/18/2008 | US20080227121 Using collagen XIII peptide as evaluative tool in identifying modulators monocyte efflux into interstitial space; treating chronic inflammatory disorders |
| 09/18/2008 | US20080227119 ELISA for VEGF |
| 09/18/2008 | US20080227117 Antitrypsin peptide marker for use in diagnosis and treatment of chronic obstructive pulmonary disease |
| 09/18/2008 | US20080227113 Lipocalin-type prostaglandin D2 synthase specific monoclonal antibody for use in diagnosis of nervous system trauma and dysfunction |
| 09/18/2008 | US20080227112 Global polyclonal antibodies, process for depleting commonly shared proteins by same, devices using same |
| 09/18/2008 | US20080227110 Expression vector comprising nucleotide sequences coding human polypeptide for use in treatment of metabolic disorders; immunotherapy |
| 09/18/2008 | US20080227106 Compositions and methods for the diagnosis and treatment of tumor |
| 09/18/2008 | US20080227097 Fluorescent protein and chromoprotein |
| 09/18/2008 | US20080226679 Novel surface exposed proteins from chlamydia pneumoniae |
| 09/18/2008 | US20080226673 Subunit vaccine against respiratory syncytial virus infection |
| 09/18/2008 | US20080226662 Nucleotide sequences coding mammalian immune system modulator (B7-DC) for use in treatment and prevention of viral infcetion a nd cell proliferative disorders; immunotherapy |
| 09/18/2008 | US20080226660 Nucleotide sequences coding human papilloma viral like particles (Hpv 58 L1) for use in designing vaccine for prevention virus associated cell proliferative disorders |
| 09/18/2008 | US20080226657 Monomethylvaline compounds capable of conjugation to ligands |
| 09/18/2008 | US20080226656 RG1 antibodies and uses thereof |
| 09/18/2008 | US20080226652 Rabies virus G protein specific immunoglobulin for use in prevention and treatment viral infection |
| 09/18/2008 | US20080226651 Envelope protein specific immunoglobulin for use in treatment and prevention human immunodeficieny virus infection |
| 09/18/2008 | US20080226650 Cotinine neutralizing antibody |
| 09/18/2008 | US20080226647 Using interferon gamma receptor 1 (IFNGR1) specific immunoglobulin for diagnosis, prevention and treatment of myxovirus infection |
| 09/18/2008 | US20080226646 Use of biomolecular targets in the treatment and visualization of tumors |
| 09/18/2008 | US20080226645 Methods and compositions for assessment and treatment of asthma |
| 09/18/2008 | US20080226644 Nucleotide sequences coding breast cancer protein (BCMP 101) for use in developing vaccines and immunoglobulin which target and destroy tumor tissues; antitumor agents |
| 09/18/2008 | US20080226643 Compositions and methods for the therapy and diagnosis of breast cancer |
| 09/18/2008 | US20080226642 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 09/18/2008 | US20080226641 Mixture comprising group B streptococcal peptide for use in generating vaccine and immunoglobulins for diagnosis, prevention and treatment of urinary tract infections |
| 09/18/2008 | US20080226639 Heparin Binding Peptide |
| 09/18/2008 | US20080226637 Hemophilus polypeptide for generating immunoglobulins and vaccines for use in prevention and treatment of bacterial infection |
| 09/18/2008 | US20080226636 Novel human ulip/CRMP protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes |
| 09/18/2008 | US20080226635 Transmembrane receptor specific immunoglobulin for use in targeting and destroying pancreatic, lung and/or breast cancers |
| 09/18/2008 | US20080226634 Tes7 and antibodies that bind thereto |
| 09/18/2008 | US20080226633 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 09/18/2008 | US20080226632 Cell growth factor specific immunoglobulin for treatment and prevention of cell proliferative and skin disorders |
| 09/18/2008 | US20080226631 Methods of modulating cytokine activity; related reagents |
| 09/18/2008 | US20080226630 Recombinant antibodies for treatment of respiratory syncytial virus infections |
| 09/18/2008 | US20080226629 Humanized vascular endothelial growth factor specific immunoglobulin for use in prevention and treatment of cell proliferative disorders; antitumor agents |
| 09/18/2008 | US20080226628 CDR-Grafted Anti-Tissue Factor Antibodies and Methods of Use Thereof |
| 09/18/2008 | US20080226627 Using clostridium botulinum neurotoxin complex (Hn-33) protein as diagnostic tool in identifying modulators for treatment and prevention of clostridial poisoning; antitumor agents |
| 09/18/2008 | US20080226626 Treating B cell malignancy via administering immunoglobulin specific for B7 polypeptides; antitumor therapy |
| 09/18/2008 | US20080226621 Antagonist anti-notch3 antibodies and their use in the prevention and treatment of notch3-related diseases |
| 09/18/2008 | US20080226620 Polypeptide comprising major histocompatibility complex epitopes for use in targeting and destroying tumor cells |
| 09/18/2008 | US20080226619 Anti-Muc1 Alpha/Beta Antibodies |
| 09/18/2008 | US20080226607 Polypeptide comprising major histocompatibility complex epitopes for use in targeting and destroying tumor cells |
| 09/18/2008 | US20080226606 Polypeptide comprising major histocompatibility complex epitopes for use in targeting and destroying tumor cells |
| 09/18/2008 | US20080226586 Expression vector comprising nucleotide sequences coding cytokine protein for diagnosis, prevention and treatment of thymus disorders |
| 09/18/2008 | US20080226549 Diagnosing cancer; measuring antibody inhibition; calibration; reduced concentration of inhibitor indicates cancer receptivity |
| 09/18/2008 | CA2703136A1 Use of ephb4 as a diagnostic marker and a therapeutic target for ovarian cancer |
| 09/18/2008 | CA2688121A1 Markers, antibodies and recombinant scfvs for mesenchymal stem cell-sub-populations and osteoclasts |
| 09/18/2008 | CA2681170A1 Methods for producing active scfv antibodies and libraries therefor |
| 09/18/2008 | CA2680914A1 Monoclonal human tumor-specific antibody |
| 09/18/2008 | CA2680613A1 Methods for generation of antibodies |
| 09/18/2008 | CA2680564A1 Sequence based engineering and optimization of single chain antibodies |